Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:715-720
doi: 10.1161/01.STR.0000249395.98417.49
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derdeyn, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derdeyn, C. P.
Related Collections
Right arrow Carotid Stenosis
Right arrow Carotid endarterectomy
Right arrow Angioplasty and Stenting

(Stroke. 2007;38:715.)
© 2007 American Heart Association, Inc.


Try It or Trial It: Introduction

Carotid Stenting for Asymptomatic Carotid Stenosis

Trial It

Colin P. Derdeyn, MD

From the Mallinckrodt Institute of Radiology and the Departments of Neurology and Neurological Surgery, Washington University School of Medicine, St. Louis, Mo.

Correspondence to Colin P. Derdeyn, MD, 510 South Kingshighway Boulevard, St Louis, MO 63110. E-mail derdeync{at}wustl.edu

Abstract

Angioplasty and stenting should not be performed for patients with asymptomatic atherosclerotic carotid bifurcation stenosis, except in the context of randomized clinical trials. Surgical carotid endarterectomy (CEA) has been proven effective over medical therapy in select asymptomatic patient populations. The benefit in these patients is small and easily overcome by procedural complication rates over 3%, owing to the relatively low risk for stroke on medical therapy. Until a randomized controlled clinical trial demonstrates reasonable equivalence of carotid angioplasty and stenting (CAS) to CEA for stroke risk reduction in asymptomatic low-surgical risk patients, there is no rationale for its use in this setting. Furthermore, there is no evidence that revascularization by either CEA or CAS is superior to medical therapy for patients that are not good surgical candidates owing to medical comorbidities or anatomic factors. Randomized trials in this high surgical risk patient population must include a medical treatment arm. In this article, we will review the existing data for CAS in patients with asymptomatic atherosclerotic carotid artery stenosis.


Key Words: angioplasty & stenting • carotid endarterectomy • carotid stenosis • outcomes • randomized controlled trials




This article has been cited by other articles:


Home page
StrokeHome page
J.-L. Mas, G. Chatellier, and for the EVA3S investigators
Carotid Angioplasty and Stenting
Stroke, January 1, 2008; 39(1): e19 - e20.
[Full Text] [PDF]


Home page
StrokeHome page
P. De Rango, P. Cao, and V. Caso
Carotid Artery Stenting: Verdict Still Pending
Stroke, July 1, 2007; 38(7): e52 - e52.
[Full Text] [PDF]


Home page
StrokeHome page
V. Hachinski
Intra-Arterial Thrombolysis for Basilar Artery Thrombosis and Stenting for Asymptomatic Carotid Disease: Implications and Future Directions
Stroke, February 1, 2007; 38(2): 721 - 722.
[Full Text] [PDF]